drugset / Trial / NCT04557878

Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction

NCT04557878

Phase 2 Completed 24 enrolled Nourhan M.Aly Alexandria University · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Purpose of the study is to compare clinically, radiographically and biochemically the effect of intra- articular injection of hypertonic dextrose with a stabilization appliance and the intra- articular injection of 2 ml of liquid phase concentrated growth factor with a stabilization appliance as a prolotherapy for temporomandibular joint anterior disc displacement without reduction.

Timeline

Start
2020-10-06
Primary completion
2021-04-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 12.5 % Other
Comparator Liquid Phase Concentrated Growth Factor Unknown 2 ml Other